Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lenacapavir”

34 trials

Showing 20 of 34 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04925752
What this trial is testing

Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection

Who this might be right for
Pre-Exposure Prophylaxis of HIV Infection
Gilead Sciences 3,292
Large-scale testing (Phase 3)Active Not RecruitingNCT06333808
What this trial is testing

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy

Who this might be right for
HIV-1-infection
Gilead Sciences 577
Testing effectiveness (Phase 2)Active Not RecruitingNCT05729568
What this trial is testing

Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection

Who this might be right for
HIV Infection
Gilead Sciences 83
Early research (Phase 1)Study completedNCT04811040
What this trial is testing

Study to Evaluate the Safety and Efficacy of Teropavimab and Zinlirvimab in Combination With Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection

Who this might be right for
HIV-1 Infection
Gilead Sciences 32
Not applicableLooking for participantsNCT06799338
What this trial is testing

Real World Use of Lenacapavir, as an add-on to an Optimized Background Regimen in France

Who this might be right for
HIV I Infection
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida 80
Testing effectiveness (Phase 2)Study completedNCT04143594
What this trial is testing

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIV

Who this might be right for
HIV-1-infection
Gilead Sciences 183
Testing effectiveness (Phase 2)Active Not RecruitingNCT06101342
What this trial is testing

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)

Who this might be right for
Pre-Exposure Prophylaxis of HIV Infection
Gilead Sciences 181
Not applicableNot Yet RecruitingNCT07402044
What this trial is testing

CABOTEGRAVIR/LENACAPAVIR DUAL LONG ACTING THERAPY (COHORT IMEA 074)

Who this might be right for
CABOTEGRAVIRLENACAPAVIR
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 50
Not applicableLooking for participantsNCT07497594
What this trial is testing

ImPrEP LEN Brasil: Twice-Yearly Lenacapavir for HIV Prevention

Who this might be right for
Contact With or Exposure to Human Immunodeficiency Virus
Oswaldo Cruz Foundation 1,500
Large-scale testing (Phase 3)Active Not RecruitingNCT06630286
What this trial is testing

Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1

Who this might be right for
HIV-1-infection
Gilead Sciences 609
Early research (Phase 1)Active Not RecruitingNCT06970223
What this trial is testing

Investigate if Long Acting Cabotegravir (CAB) and Lenacapavir (LEN) Injections Are Tolerable and Acceptable When Administered to Healthy Adults Without HIV

Who this might be right for
HIV Infections
ViiV Healthcare 65
Large-scale testing (Phase 3)Active Not RecruitingNCT04150068
What this trial is testing

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance

Who this might be right for
HIV-1-infection
Gilead Sciences 72
Post-approval studies (Phase 4)Active Not RecruitingNCT07210125
What this trial is testing

Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting

Who this might be right for
HIV
Kelley-Ross & Associates, Inc. 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT05052996
What this trial is testing

Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV

Who this might be right for
HIV-1 Infection
Gilead Sciences 142
Early research (Phase 1)Study completedNCT03739866
What this trial is testing

Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Lenacapavir Administered Subcutaneously in Human Immunodeficiency Virus (HIV) -1 Infected Adults

Who this might be right for
HIV-1 Infection
Gilead Sciences 53
Testing effectiveness (Phase 2)Looking for participantsNCT06749054
What this trial is testing

Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children

Who this might be right for
HIV-1-infection
Gilead Sciences 12
Large-scale testing (Phase 3)Active Not RecruitingNCT06544733
What this trial is testing

Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed

Who this might be right for
HIV-1-Infection
Gilead Sciences 675
Large-scale testing (Phase 3)Active Not RecruitingNCT05502341
What this trial is testing

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen

Who this might be right for
HIV-1-infection
Gilead Sciences 689
Large-scale testing (Phase 3)Active Not RecruitingNCT06630299
What this trial is testing

Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1

Who this might be right for
HIV-1-Infection
Gilead Sciences 600
Testing effectiveness (Phase 2)Active Not RecruitingNCT06513312
What this trial is testing

Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP)

Who this might be right for
Pre-Exposure Prophylaxis of HIV Infection
Gilead Sciences 268
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation